Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917798 (
cerebral ischemia
)
17,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The survival of different neuron types and the expression of the p75 neurotrophin receptor (
p75(NTR)
) after focal
cerebral ischemia
were studied in the mouse striatum using immunocytochemical and histochemical techniques and stereological procedures. As assessed at 1 week after 30 min of middle cerebral artery occlusion, the order of vulnerability was projection neurons > parvalbumin-expressing interneurons > nitric oxide synthase-containing interneurons > cholinergic interneurons. Within the ischemic lesion, projection neurons were almost completely lost whereas cholinergic interneurons were spared. Calretinin-immunoreactive interneurons also seemed resistant to the insult. Expression of
p75(NTR)
was induced in cholinergic interneurons within the lesioned area, raising the possibility of a protective action. However, the number of cholinergic interneurons was unaffected in
p75(NTR)
knockout mice subjected to the same ischemic insult. These quantitative data demonstrate that striatal neurons in the mouse are differentially susceptible to ischemic damage and argue against a significant role of
p75(NTR)
for the high resistance of cholinergic interneurons.
...
PMID:Upregulation of p75 neurotrophin receptor after stroke in mice does not contribute to differential vulnerability of striatal neurons. 1135 48
Pituitary adenylate cyclase activating peptide (PACAP), a potent neuropeptide which crosses the blood-brain barrier, is known to provide neuroprotection in rat stroke models of middle cerebral artery occlusion (MCAO) by mechanism(s) which deserve clarification. We confirmed that following i.v. injection of 30 ng/kg of PACAP38 in rats exposed to 2 h of MCAO focal
cerebral ischemia
and 48 h reoxygenation, 50 % neuroprotection was measured by reduced caspase-3 activity and volume of cerebral infarction. Similar neuroprotective effects were measured upon PACAP38 treatment of oxygen-glucose deprivation and reoxygenation of brain cortical neurons. The neuroprotection was temporally associated with increased expression of brain-derived neurotrophic factor, phosphorylation of its receptor-tropomyosin-related kinase receptor type B (trkB), activation of phosphoinositide 3-kinase and Akt, and reduction of extracellular signal-regulated kinases 1/2 phosphorylation. PACAP38 increased expression of neuronal markers beta-tubulin III, microtubule-associated protein-2, and growth-associated protein-43. PACAP38 induced stimulation of Rac and suppression of Rho GTPase activities. PACAP38 downregulated the nerve growth factor receptor (
p75(NTR)
) and associated Nogo-(Neurite outgrowth-A) receptor. Collectively, these in vitro and in vivo results propose that PACAP exhibits neuroprotective effects in
cerebral ischemia
by three mechanisms: a direct one, mediated by PACAP receptors, and two indirect, induced by neurotrophin release, activation of the trkB receptors and attenuation of neuronal growth inhibitory signaling molecules
p75(NTR)
and Nogo receptor.
...
PMID:Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models. 2267 84
The neurotrophin receptor
p75(NTR)
has been implicated in mediating neuronal apoptosis after injury to the CNS. Despite its frequent induction in pathologic states, there is limited understanding of the mechanisms that regulate
p75(NTR)
expression after injury. Here, we show that after focal
cerebral ischemia
in vivo or oxygen-glucose deprivation in organotypic hippocampal slices or neurons,
p75(NTR)
is rapidly induced. A concomitant induction of proNGF, a ligand for
p75(NTR)
, is also observed. Induction of this ligand/receptor system is pathologically relevant, as a decrease in apoptosis, after oxygen-glucose deprivation, is observed in hippocampal neurons or slices after delivery of function-blocking antibodies to
p75(NTR)
or proNGF and in
p75(NTR)
and ngf haploinsufficient slices. Furthermore, a significant decrease in infarct volume was noted in
p75(NTR)
-/- mice compared with the wild type. We also investigated the regulatory mechanisms that lead to post-ischemic induction of
p75(NTR)
. We demonstrate that induction of
p75(NTR)
after ischemic injury is independent of transcription but requires active translation. Basal levels of
p75(NTR)
in neurons are maintained in part by the expression of microRNA miR-592, and an inverse correlation is seen between miR-592 and
p75(NTR)
levels in the adult brain. After
cerebral ischemia
, miR-592 levels fall, with a corresponding increase in
p75(NTR)
levels. Importantly, overexpression of miR-592 in neurons decreases the level of ischemic injury-induced
p75(NTR)
and attenuates activation of pro-apoptotic signaling and cell death. These results identify miR-592 as a key regulator of
p75(NTR)
expression and point to a potential therapeutic candidate to limit neuronal apoptosis after ischemic injury.
...
PMID:Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury. 2457 98